Israeli artificial intelligence medical imaging analysis startup DiA Imaging Analysis today announced that the company has closed a $5 million financing round led by Connecticut Innovations with participation from Defta Healthcare, existing investors and a grant from the Israel Innovation Authority.
DiA plans will use the funds to enhance marketing of its FDA/CE-approved automated tools while at the same time expanding its portfolio and building support teams for its activities in the US, Europe and Asia.
The Beersheva based company was founded by chairman Arnon Toussia-Cohen, CEO Hila Goldman Aslan and VP R&D Michal Yaacobi.
DiA’s automated AI and imaging analysis technology delivers accurate and reproducible imaging analysis of ultrasound images. The company’s tools utilize advanced, proprietary pattern recognition and machine learning algorithms that can improve monitoring of patient conditions, offering physicians easy-to-use tools to support their decisions and improve patient outcomes.
DiA has partnered with market leaders including GE Healthcare, Neusoft Medical System, Google Cloud and others to implement its FDA/CE-approved automated tools within ultrasound devices, healthcare IT systems and cloud platforms. The company has reference cites in leading US medical centers, including Yale, Mount Sinai, RUSH, USF and UCSD. DiA’s Scientific Advisory Board is supported by world-leading physicians specializing in cardiology and primary care ultrasound.
Goldman Aslan said, "The medical imaging analysis market is expanding rapidly, while the need for automation is increasing. DiA’s innovative technology and market traction will continue bringing cutting-edge solutions to the market to improve patient care. I welcome our new investors and thank them, along with our existing investors, for their support in our vision to lead the ultrasound imaging analysis market."
"The team at DiA Imaging Analysis continues to make great strides in bringing to market their groundbreaking ultrasound analysis technology, powered by artificial intelligence, that improves patient care," said Peter Longo, Senior Managing Director for Investments at Connecticut Innovations. "We are excited about their prospects for success as we continue to support their commercialization activities."
Published by Globes [online], Israel business news - www.globes-online.com - on August 7, 2018
© Copyright of Globes Publisher Itonut (1983) Ltd. 2018